Moderna, Inc.MRNANASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -66.01% | -35.93% | -35.75% | -45.23% | -29.08% |
| Gross Profit Growth | -88.48% | -76.06% | -78.30% | -99.40% | +4.15% |
| EBITDA Growth | -502.16% | +0.00% | +0.00% | -270.89% | +0.00% |
| Operating Income Growth | -20866.67% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | -616.13% | +0.00% | +0.00% | -1638.46% | +0.00% |
| EPS Growth | -610.53% | +0.00% | +0.00% | -1608.88% | +0.00% |
| EPS Diluted Growth | -629.09% | +0.00% | +0.00% | -1664.42% | +0.00% |
| Weighted Average Shares Growth | +1.05% | +1.05% | +1.04% | +1.30% | +1.82% |
| Weighted Average Shares Diluted Growth | -2.53% | +1.05% | +1.04% | -2.26% | +1.82% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +32.64% | +0.00% | +0.00% | +0.00% | +15.27% |
| Free Cash Flow Growth | -24.63% | +0.00% | +0.00% | +0.00% | +200.99% |
| Receivables Growth | -45.24% | -20.93% | +8.04% | -24.07% | -68.92% |
| Inventory Growth | -42.08% | -56.61% | -39.85% | -19.42% | +30.77% |
| Asset Growth | -23.25% | -24.06% | -23.41% | -23.21% | -12.76% |
| Book Value per Share Growth | -22.13% | -22.28% | -20.58% | -22.78% | -22.07% |
| Debt Growth | -39.90% | -39.77% | -41.61% | +2.88% | +156.49% |
| R&D Expense Growth | -20.20% | -16.65% | -42.67% | -29.55% | -30.93% |
| SG&A Expenses Growth | -25.32% | -22.63% | -14.18% | -4.63% | -12.25% |